CAS 2126928-92-3
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Clindamycin Palmitate Hydrochloride Sulfoxide (7-Chloro-1,6,7,8-tetradeoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-methylsulfinyl-L-threo-α-D-galacto-octopyranose 2-palmitate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C34H63ClN2O7S·HClColor and Shape:White PowderMolecular weight:714.38113Clindamycin Palmitate Sulfoxide HCl
CAS:Formula:C34H63ClN2O7S·HClColor and Shape:White To Off-White SolidMolecular weight:679.40 36.46Clindamycin Palmitate Sulfoxide HCl (Mixture of Diastereomers)
CAS:Formula:C34H63ClN2O7S·HClMolecular weight:679.40 36.46Clindamycin Palmitate Sulfoxide Hydrochloride (>90%)
CAS:Controlled Product<p>Applications Clindamycin Palmiitate Sulfoxide Hydrochloride, is an impurity in the synthesis of Clindamycin Palmitate Hydrochloride (C580035), a semi-synthetic antibiotic with high bioavailability. Clindamycin Palmitate is an antibacterial.<br>References Bharathi, Ch. et al.: J. Pharm. Biomed. Anal., 48, 1211 (2008); Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006);<br></p>Formula:C34H63ClN2O7S·ClHPurity:>90%Color and Shape:NeatMolecular weight:715.85Clindamycin 2-palmitate sulfoxide
CAS:<p>Clindamycin 2-palmitate sulfoxide is a semisynthetic antibiotic, which is a derivative of clindamycin. It originates from lincomycin, a natural antibiotic produced by the bacterium *Streptomyces lincolnensis*. This compound functions as a prodrug, which is converted into its active form in the body. Its mode of action involves inhibiting bacterial protein synthesis by binding to the 50S subunit of the ribosome, thereby preventing the growth and replication of susceptible bacteria.</p>Formula:C34H64Cl2N2O7SPurity:Min. 95%Molecular weight:715.9 g/molClindamycin Palmitate Sulfoxide Hydrochloride
CAS:Formula:C34H63ClN2O7SHClMolecular weight:679.40 : 36.46
